Sanjay K. Shrestha - 20 Oct 2026 Form 4 Insider Report for Health In Tech, Inc. (HIT)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: HIT
Reported as of: 20 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Oct 2026, 21:23:45 UTC
Prior SEC filing: 10 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Lori Babcock, as attorney-in-fact for Sanjay Shrestha

Filing notes and source

Key filing fact

Sanjay K. Shrestha filed Form 4 for Health In Tech, Inc. (HIT) on 22 Oct 2026.

Key facts

This page summarizes Sanjay K. Shrestha's Form 4 filing for Health In Tech, Inc. (HIT).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 22 Oct 2026, 21:23.

Change

Previous filing in this sequence was filed on 10 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001775802 Primary reporting owner

Shrestha Sanjay K

Relationship: Chief Executive Officer, Director
Address: 701 S. COLORADO AVE, SUITE 1, STUART
Signature: /s/ Lori Babcock, as attorney-in-fact for Sanjay Shrestha
Signature date: 22 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HIT transaction

Class A Common Stock

Award

Transaction value
Shares: +2,000,000
Change %: +1976%
Price: $0.000000^*
Shares after: 2,101,200
Date: 20 Oct 2026
Ownership: Direct
Footnotes: F1

HIT transaction

Class A Common Stock

Award

Transaction value
Shares: +1,500,000
Change %: +71%
Price: $0.000000^*
Shares after: 3,601,200
Date: 20 Oct 2026
Ownership: Direct
Footnotes: F2

HIT transaction

Class A Common Stock

Award

Transaction value
Shares: +1,500,000
Change %: +42%
Price: $0.000000^*
Shares after: 5,101,200
Date: 20 Oct 2026
Ownership: Direct
Footnotes: F3

HIT transaction

Class B Common Stock

Award

Transaction value
Shares: +500,000
Change %
Price: $0.000000^*
Shares after: 500,000
Date: 20 Oct 2026
Ownership: Direct
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents restricted shares granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan upon his appointment as CEO ("Shares"). Such Shares vest in twelve equal monthly installments, commencing November 1, 2026, subject to continued service through the applicable vesting date.

Footnote F2

Represents Shares which shall be automatically forfeited without consideration unless a performance-based acquisition milestone is achieved by December 31, 2028. Such Shares vest in full upon the closing of a qualifying acquisition, subject to continued service through such closing.

Footnote F3

Represents Shares which shall be automatically forfeited without consideration unless a certain performance-based milestone (the "Milestone") is achieved by April 30, 2028 (the "Achievement Date"). Such Shares vest in twelve equal monthly installments, subject to continued service. If the Achievement Date falls before the 15th calendar day of the month, vesting commences on such 15th day, and if after, commences on the 1st day of the next calendar month.

Footnote F4

Represents Shares which shall be automatically forfeited without consideration unless the Milestone is achieved by the Achievement Date. Such Shares vest in twelve equal monthly installments, subject to continued service. If the Achievement Date falls before the 15th calendar day of the month, vesting commences on such 15th day, and if after, commences on the 1st day of the next calendar month.